Northeast Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000597.SZ

Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.30

Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio is 0.30 for the year ending December 31, 2023, a -39.75% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.49, a -40.28% change year over year.
Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.82, a -7.00% change year over year.
Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.88, a -14.61% change year over year.
Northeast Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 1.03, a 17.66% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Shenzhen Stock Exchange: 000597.SZ

Northeast Pharmaceutical Group Co., Ltd.

CEO	Mr. Zhou Kai
IPO Date	May 23, 1996
Location	China
Headquarters	No.8 Kunminghu Street
Employees	6,214
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Fertilizers Non-Alcoholic Beverages Personal Care Petrochemicals Plastics

Description

Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products; API products comprising fosfomycin, anti-aids, and other products; and chemical products, including chemical and pharmaceutical intermediates, chiral separation reagent products, etc. The company also provides digestives, narcotic medicines, cardiovascular, cerebrovascular medicines, etc. In addition, it engages in medical distribution business. Northeast Pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Shenyang, China.

Key trends

Past 5 years